Newsroom | Arnold Ventures

Statement from Arnold Ventures Executive Vice President of Health Care, Mark E. Miller on the Additional $16 Billion in Plan Payments in Proposed Medicare Advantage and Part‑D Rate Notice

02.01.2024

Serious Medical Errors Rose After Private Equity Firms Bought Hospitals

The New York Times 12.26.2023

Statement From Arnold Venture’s Mark E. Miller on the U.S. House of Representatives Passage of the Lower Costs, More Transparency Act, a Critical Step Forward in Addressing Rising Health Care Costs

12.12.2023

Health Policy Leaders Launch Coalition to Protect Consumers and Employers from Predatory Health Care Pricing

09.13.2023

Congress Authorizes Overhaul of Troubled Organ Transplant System

The Washington Post 07.28.2023

Hospitals Are in the Hotseat for Their Billing Practices

Axios 07.26.2023

New Law Goes Into Effect to Strengthen The Maryland Prescription Drug Affordability Board

04.11.2023

Statement from Arnold Ventures’ Mark E. Miller on Biden Administration’s Decision to Slow Implementation of Medicare Advantage Reforms

03.31.2023

California Selects Civica Rx as Its Insulin Manufacturing Partner

03.20.2023

New Survey Shows Americans Overwhelmingly Believe Congress and the Administration Should Crack Down on Medicare Advantage Insurers for Abusive Billing Practices

03.20.2023

The Challenges Facing America’s Health Care System

Houston Public Media 03.03.2023

Tonya Ingram Feared the Organ Donation System Would Kill Her. It Did.

The New York Times 02.03.2023

How a Drug Company Made $114 Billion by Gaming the U.S. Patent System

The New York Times 02.03.2023

Hospitals have a target on their backs

Axios 11.09.2022

Statement on the Biden Administration’s Final Regulations to Implement the No Surprises Act

08.19.2022

Statement from Laura and John Arnold on Landmark Law to Lower Prescription Drug Prices

08.16.2022

Statement from Laura and John Arnold Following Senate Passage of the Inflation Reduction Act of 2022

08.07.2022

Bill aimed at lowering Medicare drug prices faces next test in the Senate

CNN 07.21.2022

“It’s time to finish the job.”: Statement from Mark E. Miller on Historic Opportunity for Congress to Lower Prescription Drug Prices

06.30.2022

Statement from Mark E. Miller on Medicare Advantage Oversight Hearing

06.27.2022

Statement from Mark E. Miller on New Insulin Legislation Offered in Senate

06.23.2022

When routine medical tests trigger a cascade of costly, unnecessary care

NPR 06.13.2022

The Billionaire Funding a Battle Against Hospital Monopolies

Wall Street Journal 06.13.2022

What’s Driving Up Medicare Part D Costs? High Brand-Name Drug Net Prices And A Shift To High-Cost Specialty Drugs

Health Affairs 04.21.2022